NMPA Issued the Announcement on Revising the Package Inserts of Prescription and Over-the-counter Oral Preparations such as Huoxuezhitong Capsules
In accordance with the results of the Adverse Drug Reaction Evaluation, in order to further ensure the safety of public medication, on November 8, 2019, NMPA issued an Announcement with decisions made to revise the Entries of [warnings], [adverse reactions], [contraindications] and [precautions] of oral preparations (tablets, powders, soft capsules, capsules) such as Huoxuezhitong capsules.